Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The U.S. market for vascular access devices is projected to be worth more than $2 billion by 2022, according to a Decision Resources Group news release.
Mundelein, Ill.-based Medline has announced an agreement to purchase cleaning and disinfectant technologies from Niles, Ill.-based Medtrol, a sanitizer and disinfectant manufacturer.
Roseville, Calif.-based Adventist Health Hospitals has signed an agreement to use Aperek Ellipse, a spend visibility and analytics solution.
Irving Park, Texas-based VHA has partnered with Alpharetta, Ga.-based Care Logistics to provide its member hospitals Care Logistics' Hospital Operating System™, a care coordination model and technology system, according to the companies.
Brentwood, Tenn.-based HealthTrust has selected Melville, N.Y.-based Canon U.S.A and Boca Raton, Fla.-based Virtual Imaging, a wholly owned Canon subsidiary, to provide RadPRO Digital Radiology systems for its member hospitals, according to a joint news release by the companies.
London, England-based Smith & Nephew and Austin-based ArthroCare Corp. have received early termination of the waiting period mandated by antitrust law, satisfying one of the requirements for Smith & Nephew's acquisition of AthroCare.
Mundelein, Ill.-based Medline will have exclusive distribution rights of King of Prussia, Pa.-based Devon Medical Products that treat lymphedema.
Roswell, Ga.-based Kimberly-Clark Health Care and St. Paul, Minn.-based 3M have formed an alliance to provide surgical and infection prevention solutions to healthcare facilities.
The U.S. Food and Drug Administration has approved a Supplemental New Drug Application for Bristol-Myers Squibb/Pfizer's Eliquis (apixaban) as a preventative measure against potential pulmonary embolism-causing blood clots for patients who have undergone hip or knee replacement therapy, according to…
Dublin, Ireland-based Shire Pharmaceuticals has issued a voluntary recall on three lots of VPRIV, a long-term intravenous enzyme replacement therapy for patients with type 1 Gaucher disease, due to stainless steel and barium sulfate particulate matter found in a few…